{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:03:10Z","timestamp":1759104190183,"version":"3.44.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.jneuroim.2012.07.002","type":"journal-article","created":{"date-parts":[[2012,8,2]],"date-time":"2012-08-02T14:15:38Z","timestamp":1343916938000},"page":"103-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis"],"prefix":"10.1016","volume":"251","author":[{"given":"P.","family":"Tewarie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.E.","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.D.","family":"Dijkstra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heijnen","family":"D.A.M.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Balk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Vrenken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.H.","family":"Polman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Killestein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2012.07.002_bb0005","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1177\/1352458511433303","article-title":"Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosis","volume":"18","author":"Avsar","year":"2012","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0010","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJMoa022328","article-title":"Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event","volume":"349","author":"Berger","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0015","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/brain\/awh176","article-title":"Development of biomarkers in multiple sclerosis","volume":"127","author":"Bielekova","year":"2004","journal-title":"Brain"},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jneuroim.2006.03.014","article-title":"Myelin flow cytometry assay detects enhanced levels of antibodies to human whole myelin in a subpopulation of multiple sclerosis patients","volume":"176","author":"Breij","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0025","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1001\/archneurol.2010.197","article-title":"Intrathecal anti-MOG antibody production is elevated in multiple sclerosis","volume":"67","author":"Klawiter","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0030","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1056\/NEJMoa063602","article-title":"Lack of association between antimyelin antibodies and progression to multiple sclerosis","volume":"356","author":"Kuhle","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0035","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00415-006-0299-4","article-title":"Antimyelin antibodies in clinically isolated syndromes correlate with inflammation in MRI and CSF","volume":"254","author":"Kuhle","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0040","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0045","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1191\/1352458505ms1187sr","article-title":"Anti-myelin antibodies do not allow earlier diagnosis of multiple sclerosis","volume":"11","author":"Lim","year":"2005","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0050","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","article-title":"Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis","volume":"50","author":"McDonald","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0060","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nrneurol.2011.45","article-title":"Roles of anti-MOG antibodies in demyelinating diseases","volume":"7","author":"Olsson","year":"2011","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0065","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1212\/WNL.0b013e318247f9f3","article-title":"Antigen microarrays identify CNS-produced auto-antibodies in RRMS","volume":"78","author":"Quintana","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jneuroim.2006.06.028","article-title":"Antibodies as biological markers for pathophysiological processes in MS","volume":"180","author":"Reindl","year":"2006","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0075","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1177\/1352458511399614","article-title":"Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry","volume":"17","author":"Teunissen","year":"2011","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0080","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1177\/1352458507077622","article-title":"Anti-myelin antibodies predict the clinical outcome after a first episode suggestive of MS","volume":"13","author":"Tomassini","year":"2007","journal-title":"Mult. Scler."},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0165-5728(97)00075-1","article-title":"T cell response to myelin basic protein in the context of the multiple sclerosis-associated HLA-DR15 haplotype: peptide binding, immunodominance and effector functions of T cells","volume":"77","author":"Vergelli","year":"1997","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0090","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/jnnp.2008.146357","article-title":"Cerebrospinal fluid ant-myelin antibodies are related to magnetic resonance measures of disease activity in multiple sclerosis","volume":"80","author":"Vogt","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2012.07.002_bb0095","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.bbadis.2010.06.009","article-title":"The role of antibodies in multiple sclerosis","volume":"1812","author":"Weber","year":"2011","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812002147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572812002147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:19:22Z","timestamp":1759047562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572812002147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":19,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0165572812002147"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.07.002","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2012,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebrospinal fluid anti-whole myelin antibodies are not correlated to magnetic resonance imaging activity in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2012.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}